 |
 | Vissza |
Pascual Javier; Gil-Gil Miguel; Proszek Paula; Zielinski Christoph; Reay Alistair; Ruiz-Borrego Manuel; Cutts Rosalind; Ciruelos Gil Eva M; Feber Andrew; Muñoz-Mateu Montserrat; Swift Claire; Bermejo Begoña; Herranz Jesus; Kahán Zsuzsanna; Csöszi Tibor:
Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients.
CLINICAL CANCER RESEARCH, 29 (20).
pp. 4166-4177.
ISSN 1078-0432
(2023)
Zielinski Christoph; Láng István; Beslija Semir; Kahán Zsuzsanna; Inbar Moshe J.; Stemmer Salomon M.; Anghel Rodica; Vrbanec Damir; Messinger Diethelm; Brodowicz Thomas:
Predictive role of hand-foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer.
BRITISH JOURNAL OF CANCER, 114.
pp. 163-170.
ISSN 0007-0920
(2016)
Brodowicz Thomas; Láng István; Kahán Zsuzsanna; Greil R.; Beslija Semir; Stemmer Salomon M.; Kaufman B.; Petruzelka L.; Eniu A.; Anghel Rodica; Koynov K.; Vrbanec Damir; Pieńkowski Tadeusz; Melichar B.; Spanik S.; Ahlers S.; Messinger Diethelm; Inbar Moshe J.; Zielinski Christoph:
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.
BRITISH JOURNAL OF CANCER, 111 (11).
pp. 2051-2057.
ISSN 0007-0920
(2014)
